An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia

Nature Genetics

Volumn 18, Issue 1, 1998, Pages 49-52

  Wiestner, Adrian ^a   Schlemper, Ronald J ^b   Van Der Maas, Anthonie P C ^c   Skoda, Radek C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b FUKUOKA UNIVERSITY   (Japan)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; THROMBOPOIETIN;

ARTICLE; CELL PROLIFERATION; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; HYPOTHESIS; INTRON; MEGAKARYOPOIESIS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTHEMIA; THROMBOCYTOPOIESIS;

ANIMALS; COS CELLS; FEMALE; HUMANS; INTRONS; MALE; MUTATION; PEDIGREE; PLATELET COUNT; RATS; RNA SPLICING; THROMBOCYTOSIS; THROMBOPOIETIN; TUMOR CELLS, CULTURED;

EID: 0031975482     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0198-49     Document Type: Article

References (28)

1. Murphy, S., Peterson, P., Hand, H. & Laszlo, J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin. Hematol. 34, 29-39 (1997).
2. Pickers, M. & Speck, B. Thrombocythaemia: familial occurrence and transition into blastic crisis. Acta Haematol. 51, 257-265 (1974).
3. Slee, P.H.T.J., van Everdingen, J.J.E., Geraedts, J.P.M., te Velde, J. & den Ottolander, G.J. Familial myeloproliferative disease. Acta Med. Scand. 210, 321-327 (1981).
4. Eyster, M.E. et al. Familial essential thrombocythemia. Am. J. Med. 80, 497-502 (1986).
5. Fernandez-Robles, E., Vermylen, C., Martiat, P., Ninane, J. & Cornu, G. Familial essential thrombocythemia. Pediatr. Hematol. Onml. 7, 373-376 (1990).
6. Williams, E.G. & Shahidi, N.T. Benign familial thrombocytosis. Am. J. Hematol. 37, 124-125 (1991).
7. Schlemper, R.J., van der Maas, A.P.C. & Eikenboom, J.CJ. Familial essential thrombocythemia: clinical characteristics of 11 cases in one family. Ann. Hematol. 68, 153-158 (1994).
8. Kikuchi, M. et al. Familial thrombocytosis. Br. J. Haematol. 89, 900-902 (1995).
9. Kaushansky, K. Thrombopoietin: understanding and manipulating platelet production. Annu. Rev. Med. 48, 1-11 (1997).
10. Eaton, D.L & de Sauvage, F.J. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp. Hematol. 25, 1-7 (1997).
11. van Dijken, P.J., Woldendorp, K.H. & van Wouwe, J.P. Familial thrombocytosis in infancy presenting with a leukaernoid reaction. Acta Paediatr. 85, 1132-1134 (1996).
12. Kaushansky, K. et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369, 568-571 (1994).
13. Zhou, W., Toombs, C.F., Zou, T., Guo, J. & Robinson, M.O. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 89, 1551-1559 (1997).
14. Yan, X. Q. et al. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86, 4025-4033 (1995).
15. Tahara, T. et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br. J. Haematol. 93, 783-788 (1996).
16. Krawczak, M., Reiss, J. & Cooper, D.N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90, 41-54 (1992).
17. Chang, M.S. et al. Cloning and characterization of the human megakaryocyte growth and development factor (mgdf) gene. J. Biol. Chem. 270, 511-514 (1995).
18. Sohma, Y. et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett. 353, 57-61 (1994).
19. Kamura, T., Manda, H., Hamasaki, N. & Kitajima, S. Characterization of the human thrombopoietin gene promoter - ́ possible role of an Ets transcription factor, E4TF1/GABP. J. Biol. Chem. 272, 11361-11368 (1997).
20. Nielsen, H., Engelbrecht, E., Brunak, S. & von Heijne, G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10, 1-6 (1997).
21. Stoffel, R., Wiestner, A. & Skoda, R.C. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets, Blood 87, 567-573 (1996).
22. Sachs, A.B., Sarnow, P. & Hentze, M.W. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 89, 831-838 (1997).
23. Jackson, R.J. & Wickens, M. Translational controls impinging on the 5′-untranslated region and initiatio factor proteins. Curr. Opin. Genet Devel. 7, 233-241 (1997).
24. D'Andréa, A.D. Cytokine receptors in congenital hematopoietic disease. N. Engl. J. Med. 330, 839-846 (1994).
25. Ott, J. A computer program for linkage analysis of general human pedigrees. Am. J. Hum. Genet. 28, 528-529 (1967).
26. Chomczynski, P. & Sachhi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162, 156-159 (1987).
27. Seed, B. & Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA 84, 3365-3369 (1987).
28. Berger, J., Hauber, J., Hauber, R., Geiger, R. & Cullen, B.R. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66, 1-10 (1988).